Polysaccharide-Based Theranostic Systems for Combined Imaging and Cancer Therapy: Recent Advances and Challenges

Abstract

Designing novel systems for efficient cancer treatment and improving the quality of life for patients is a prime requirement in the healthcare sector. In this regard, theranostics have recently emerged as a unique platform, which combines the benefits of both diagnosis and therapeutics delivery. Theranostics have the desired contrast agent and the drugs combined in a single carrier, thus providing the opportunity for real-time imaging to monitor the therapy results. This helps in reducing the hazards related to treatment overdose or underdose and gives the possibility of personalized therapy. Polysaccharides, as natural biomolecules, have been widely explored to develop theranostics, as they act as a matrix for simultaneously loading both contrast agents and drugs for their utility in drug delivery and imaging. Additionally, their remarkable physicochemical attributes (biodegradability, satisfactory safety profile, abundance, and diversity in functionality and charge) can be tuned via postmodification, which offers numerous possibilities to develop theranostics with desired characteristics. Hence, we provide an overview of recent advances in polysaccharide matrix-based theranostics for drug delivery combined with magnetic resonance imaging, computed tomography, positron emission tomography, single photon emission computed tomography, and ultrasound imaging. Herein, we also summarize the toxicity assessment of polysaccharides, associated contrast agents, and nanotoxicity along with the challenges and future research directions.

A Comprehensive Review on Barium Titanate Nanoparticles as a Persuasive Piezoelectric Material for Biomedical Applications: Prospects and Challenges

“…The translation of nanoparticles based biomedical approaches from in vitro assessment to in vivo platform may sometimes leads to contradicting results. [268] The administration of nanoparticles in vivo aims in treating the targeted pathological condition with minimal harm to the health tissues, hence the toxicity assessment and evaluation of adequate dose rate is a crucial factor which needs a careful examination. Although the underlying mechanism concerning the toxicity of BaTiO 3 NPs is still in progress however, oxidative damage due to over [266] Copyright 2021, American Chemical Society.…”

Dextran/eudragit S-100 based redox sensitive nanoparticles for colorectal cancer therapy

“…13,14 Recently, extensive research has been done to utilize modern nanotechnology based concepts with various natural and synthetic polymers for developing a suitable drug delivery system. [15][16][17] Natural polymers display inherent biocompatibility and biodegradability, making them a suitable candidate for preparing a carrier matrix. [18][19][20] On the other hand, synthetic polymers provide the possibility of having the desired functional groups and tuning the physicochemical properties by adjusting the synthetic strategy.…”

Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives

“…Recently, there have been great advances in polysaccharide matrix-based, controlled therapeutic delivery and target site imaging theranostics for drug delivery combined with medical imaging modalities such as MRI, PET, and fluorescent probes. This is an extremely versatile new type of drug delivery system with targeted tracer development and intuitive applications that make it easier for theranostics to streamline diagnoses and therapies [ 210 ]. Molecular imaging is foremost and is essential in theranostics.…”